Literature DB >> 24421047

T-bet regulates immunity to Francisella tularensis live vaccine strain infection, particularly in lungs.

Amanda A Melillo1, Oded Foreman, Catharine M Bosio, Karen L Elkins.   

Abstract

Upregulation of the transcription factor T-bet is correlated with the strength of protection against secondary challenge with the live vaccine strain (LVS) of Francisella tularensis. Thus, to determine if this mediator had direct consequences in immunity to LVS, we examined its role in infection. Despite substantial in vivo gamma interferon (IFN-γ) levels, T-bet-knockout (KO) mice infected intradermally (i.d.) or intranasally (i.n.) with LVS succumbed to infection with doses 2 log units less than those required for their wild-type (WT) counterparts, and exhibited significantly increased bacterial burdens in the lung and spleen. Lungs of LVS-infected T-bet-KO mice contained fewer lymphocytes and more neutrophils and interleukin-17 than WT mice. LVS-vaccinated T-bet-KO mice survived lethal LVS intraperitoneal secondary challenge but not high doses of LVS i.n. challenge, independently of the route of vaccination. Immune T lymphocytes from the spleens of i.d. LVS-vaccinated WT or KO mice controlled intracellular bacterial replication in an in vitro coculture system, but cultures with T-bet-KO splenocyte supernatants contained less IFN-γ and increased amounts of tumor necrosis factor alpha. In contrast, immune T-bet-KO lung lymphocytes were greatly impaired in controlling intramacrophage growth of LVS; this functional defect is the likely mechanism underpinning the lack of respiratory protection. Taken together, T-bet is important in host resistance to primary LVS infection and i.n. secondary challenge. Thus, T-bet represents a true, useful correlate for immunity to LVS.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24421047      PMCID: PMC3993391          DOI: 10.1128/IAI.01545-13

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  41 in total

1.  A novel transcription factor, T-bet, directs Th1 lineage commitment.

Authors:  S J Szabo; S T Kim; G L Costa; X Zhang; C G Fathman; L H Glimcher
Journal:  Cell       Date:  2000-03-17       Impact factor: 41.582

2.  Susceptibility to secondary Francisella tularensis live vaccine strain infection in B-cell-deficient mice is associated with neutrophilia but not with defects in specific T-cell-mediated immunity.

Authors:  C M Bosio; K L Elkins
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

3.  T-bet regulates IgG class switching and pathogenic autoantibody production.

Authors:  Stanford L Peng; Susanne J Szabo; Laurie H Glimcher
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-16       Impact factor: 11.205

4.  Multiple mechanisms of NADPH oxidase inhibition by type A and type B Francisella tularensis.

Authors:  Ramona L McCaffrey; Justin T Schwartz; Stephen R Lindemann; Jessica G Moreland; Blake W Buchan; Bradley D Jones; Lee-Ann H Allen
Journal:  J Leukoc Biol       Date:  2010-07-07       Impact factor: 4.962

5.  Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells.

Authors:  Susanne J Szabo; Brandon M Sullivan; Claudia Stemmann; Abhay R Satoskar; Barry P Sleckman; Laurie H Glimcher
Journal:  Science       Date:  2002-01-11       Impact factor: 47.728

6.  Different host defences are required to protect mice from primary systemic vs pulmonary infection with the facultative intracellular bacterial pathogen, Francisella tularensis LVS.

Authors:  J Wayne Conlan; Rhonda KuoLee; Hua Shen; Ann Webb
Journal:  Microb Pathog       Date:  2002-03       Impact factor: 3.738

7.  T-bet-independent effects of IL-12 family cytokines on regulation of Th17 responses to experimental T. cruzi infection.

Authors:  Dustin Cobb; Derek Hambright; Ronald B Smeltz
Journal:  J Leukoc Biol       Date:  2010-08-31       Impact factor: 4.962

8.  Interleukin-17 is required for T helper 1 cell immunity and host resistance to the intracellular pathogen Francisella tularensis.

Authors:  Yinyao Lin; Shane Ritchea; Alison Logar; Samantha Slight; Michelle Messmer; Javier Rangel-Moreno; Lokesh Guglani; John F Alcorn; Heather Strawbridge; Sang Mi Park; Reiko Onishi; Nikki Nyugen; Michael J Walter; Derek Pociask; Troy D Randall; Sarah L Gaffen; Yoichiro Iwakura; Jay K Kolls; Shabaana A Khader
Journal:  Immunity       Date:  2009-10-22       Impact factor: 31.745

9.  Control of effector CD8+ T cell function by the transcription factor Eomesodermin.

Authors:  Erika L Pearce; Alan C Mullen; Gislâine A Martins; Connie M Krawczyk; Anne S Hutchins; Valerie P Zediak; Monica Banica; Catherine B DiCioccio; Darrick A Gross; Chai-An Mao; Hao Shen; Nezih Cereb; Soo Y Yang; Tullia Lindsten; Janet Rossant; Christopher A Hunter; Steven L Reiner
Journal:  Science       Date:  2003-11-07       Impact factor: 47.728

10.  Multiple T cell subsets control Francisella tularensis LVS intracellular growth without stimulation through macrophage interferon gamma receptors.

Authors:  Siobhán C Cowley; Karen L Elkins
Journal:  J Exp Med       Date:  2003-07-28       Impact factor: 14.307

View more
  13 in total

1.  IL-21 Receptor Signaling Is Essential for Optimal CD4+ T Cell Function and Control of Mycobacterium tuberculosis Infection in Mice.

Authors:  Satyanarayana Swamy Cheekatla; Deepak Tripathi; Sambasivan Venkatasubramanian; Padmaja Paidipally; Elwyn Welch; Amy R Tvinnereim; Roza Nurieva; Ramakrishna Vankayalapati
Journal:  J Immunol       Date:  2017-08-30       Impact factor: 5.422

Review 2.  The evolving role of T-bet in resistance to infection.

Authors:  Gretchen Harms Pritchard; Ross M Kedl; Christopher A Hunter
Journal:  Nat Rev Immunol       Date:  2019-06       Impact factor: 53.106

Review 3.  Differential Immune Response Following Intranasal and Intradermal Infection with Francisella tularensis: Implications for Vaccine Development.

Authors:  McKayla J Nicol; David R Williamson; David E Place; Girish S Kirimanjeswara
Journal:  Microorganisms       Date:  2021-04-30

4.  Francisella tularensis Vaccines Elicit Concurrent Protective T- and B-Cell Immune Responses in BALB/cByJ Mice.

Authors:  Roberto De Pascalis; Lara Mittereder; Alicia Y Chou; Nikki J Kennett; Karen L Elkins
Journal:  PLoS One       Date:  2015-05-14       Impact factor: 3.240

5.  Downmodulation of vaccine-induced immunity and protection against the intracellular bacterium Francisella tularensis by the inhibitory receptor FcγRIIB.

Authors:  Brian J Franz; Ying Li; Constantine Bitsaktsis; Bibiana V Iglesias; Giang Pham; Raju Sunagar; Sudeep Kumar; Edmund J Gosselin
Journal:  J Immunol Res       Date:  2015-04-19       Impact factor: 4.818

6.  Models derived from in vitro analyses of spleen, liver, and lung leukocyte functions predict vaccine efficacy against the Francisella tularensis Live Vaccine Strain (LVS).

Authors:  Roberto De Pascalis; Alicia Y Chou; Patrik Ryden; Nikki J Kennett; Anders Sjöstedt; Karen L Elkins
Journal:  mBio       Date:  2014-04-08       Impact factor: 7.867

Review 7.  Host-pathogen interactions and immune evasion strategies in Francisella tularensis pathogenicity.

Authors:  Don J Steiner; Yoichi Furuya; Dennis W Metzger
Journal:  Infect Drug Resist       Date:  2014-09-18       Impact factor: 4.003

8.  An In Vitro Co-culture Mouse Model Demonstrates Efficient Vaccine-Mediated Control of Francisella tularensis SCHU S4 and Identifies Nitric Oxide as a Predictor of Efficacy.

Authors:  Igor Golovliov; Helena Lindgren; Kjell Eneslätt; Wayne Conlan; Amandine Mosnier; Thomas Henry; Anders Sjöstedt
Journal:  Front Cell Infect Microbiol       Date:  2016-11-25       Impact factor: 5.293

9.  Vaccine-Mediated Mechanisms Controlling Replication of Francisella tularensis in Human Peripheral Blood Mononuclear Cells Using a Co-culture System.

Authors:  Kjell Eneslätt; Igor Golovliov; Patrik Rydén; Anders Sjöstedt
Journal:  Front Cell Infect Microbiol       Date:  2018-02-07       Impact factor: 5.293

10.  Mice Deficient in T-bet Form Inducible NO Synthase-Positive Granulomas That Fail to Constrain Salmonella.

Authors:  Marisol Perez-Toledo; Nonantzin Beristain-Covarrubias; William M Channell; Jessica R Hitchcock; Charlotte N Cook; Ruth E Coughlan; Saeeda Bobat; Nicholas D Jones; Kyoko Nakamura; Ewan A Ross; Amanda E Rossiter; Jessica Rooke; Alicia Garcia-Gimenez; Sian Jossi; Ruby R Persaud; Edith Marcial-Juarez; Adriana Flores-Langarica; Ian R Henderson; David R Withers; Steve P Watson; Adam F Cunningham
Journal:  J Immunol       Date:  2020-06-26       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.